Want more information on our services?
Send us a message using the form below.
Discover The Therapeutic Potential of GLP1 Medications at Lotus Weight Loss & Wellness in Central KY
Current research on GLP1 medications suggests they have the potential to treat various medical conditions. Semaglutide, a GLP1 drug, was first approved for type 2 diabetes in 2017, but the STEP trial in 2021 revealed its ability to also treat obesity. Ongoing studies are examining how this class of medication could be used to address other chronic health problems.
Which Works Better: Semaglutide VS Tirzepatide
Weight loss can seem like an overwhelming challenge, as it often becomes much more difficult and costly to maintain a healthy diet and adhere to a daily exercise routine. It's reassuring to know that in today's world, we have access to medications that can assist us in facing these overwhelming challenges. Everyone at this point has heard of Semaglutide and Tirzepatide or their class of drugs called GLP1’s. There is no doubt that we must do the hard work of exercising and consuming a healthy diet to lose weight, but it is nice to know that we have a tool that can help support and boost our efforts. The main question we get asked is which medication works better, so in this post, I will try and break down some of the main points to make your decision easier.